Hualan Biological Bacterin Inc.’s Net Profit Dropped 16.3% in 2022

Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 519.6 million yuan in 2022, down 16.3% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, down 0.2% year-on-year.

At the end of the reporting period, it had 7.1 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 22.3%.